Latest progress in tyrosine kinase inhibitors

Here we discuss the latest progress in development of some kinase inhibitors such as inhibitors of c-MET, LIM and Bcr-Abl kinases. Importantly, many oncogenic kinases signal via the mTOR pathway, suggesting a common target for drug combinations.

Na minha lista:
Bibliografiske detaljer
Main Authors: Pospelova, Tatiana V., Pospelov, Valery A.
Format: Artigo
Sprog:Inglês
Udgivet: Impact Journals LLC 2014
Fag:
Research Perspective
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4012733/
https://ncbi.nlm.nih.gov/pubmed/24727648
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker